Health Care & Life Sciences » Pharmaceuticals | China Resources Double-Crane Pharmaceutical Co. Ltd.

China Resources Double-Crane Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,779
5,091
5,067
5,402
6,311
8,078
Cost of Goods Sold (COGS) incl. D&A
4,524
2,561
2,514
2,643
2,842
3,152
Gross Income
2,255
2,530
2,553
2,758
3,470
4,925
SG&A Expense
1,442
1,671
1,766
1,870
2,443
3,797
EBIT
776
-
762
896
1,017
1,133
Unusual Expense
-
-
1
15
27
2
Non Operating Income/Expense
262
2
1
16
46
30
Interest Expense
29
13
7
3
1
9
Pretax Income
1,067
881
807
907
1,054
1,184
Income Tax
193
142
142
168
172
195
Consolidated Net Income
873
739
665
739
882
989
Net Income
871
737
661
714
843
969
Net Income After Extraordinaries
871
737
661
714
843
969
Net Income Available to Common
871
737
661
714
843
969
EPS (Basic)
1.06
0.89
0.63
0.68
0.81
0.93
Basic Shares Outstanding
823
823
1,043
1,043
1,043
1,043
EPS (Diluted)
1.06
0.89
0.63
0.68
0.81
0.93
Diluted Shares Outstanding
823
823
1,043
1,043
1,043
1,043
EBITDA
1,045
1,121
1,024
1,192
1,355
1,481
Other Operating Expense
37
2
25
7
10
4
Non-Operating Interest Income
17
32
51
12
18
20
Minority Interest Expense
3
2
4
25
39
21

About China Resources Double-Crane Pharmaceutical Co.

View Profile
Address
No. 1 Lize East 2nd Road
Beijing Beijing 100102
China
Employees -
Website http://www.dcpc.com
Updated 07/08/2019
China Resources Double-Crane Pharmaceutical Co., Ltd. engages in the drug development, manufacturing, and sale. It focuses on injection, cardiovascular and cerebrovascular, endocrinology, and pediatric field. It specializes in slow disease general medicine business, specialist business, and infusion business.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.